ASX 200 Stocks in Focus Following Recent Market Decline

3 min read | April 16, 2025 06:30 PM AEST | By Team Kalkine Media

Highlights

  • James Hardie Industries continues to benefit from rising demand for fibre cement in North America

  • ResMed maintains market presence with its respiratory care product portfolio and recurring revenue base

  • Telix Pharmaceuticals records earnings growth supported by Illuccix and clinical pipeline expansion

Building Materials Sector: James Hardie Industries plc (ASX:JHX)

James Hardie Industries operates in the fibre cement building products sector with primary exposure to the housing and renovation market in North America. Industry feedback highlights a long-term transition in building materials from vinyl and timber to fibre cement, which supports the company’s revenue outlook. Structural demand for new housing in the United States remains a key factor in maintaining consistent product demand.

The company’s focus on sustainable and durable construction materials aligns with ongoing industry trends. Expansion efforts in the North American residential housing market and increased renovation activity continue to support product adoption.

Healthcare Sector: ResMed Inc. (ASX:RMD)

ResMed operates in the medical device sector with a focus on respiratory care solutions including CPAP devices used for sleep apnea treatment. Industry research highlights the company’s recurring revenue stream driven by consumables and device replacement cycles.

ResMed holds a strong market presence and has maintained growth through new product launches and geographical expansion. Demand for at-home healthcare solutions, especially for chronic respiratory conditions, remains a core contributor to business performance.

Biotechnology Sector: Telix Pharmaceuticals Ltd (ASX:TLX)

Telix Pharmaceuticals operates in the biotechnology sector, focusing on radiopharmaceuticals for oncology and rare diseases. The company has generated revenue through Illuccix, which is used in prostate cancer imaging. The expansion of its product pipeline includes Gozellix and Zircaix, aimed at different therapeutic areas.

Clinical trials and regulatory progress across multiple programs have drawn attention to the company's broader portfolio. Its strategy includes progressing assets through late-stage development while expanding commercial access for approved products.

Technology Sector: Altium Limited (ASX:ALU)

Altium operates in the software development space, providing electronic design automation tools for printed circuit board design. The shift towards advanced electronics across consumer and industrial applications continues to drive software demand.

The company has increased its global user base by integrating design tools into cloud-based ecosystems, enhancing user collaboration and product innovation. Recurring revenue through licensing and subscriptions remains a focus area as part of its business model.

Retail Sector: JB Hi-Fi Limited (ASX:JBH)

JB Hi-Fi engages in the retail sector with operations across consumer electronics and home appliances. Market data shows continued consumer interest in audio-visual equipment and computing products, contributing to consistent sales volumes.

The company’s performance is supported by its focus on competitive pricing, broad product range, and strong in-store and online presence. Seasonal promotions and product launches across entertainment and technology categories remain part of the core retail strategy.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.